Fda Takes Steps To Improve Hearing Aid Accessibility

Fda Takes Steps To Improve Hearing Aid Accessibility

The U.S. Food and Drug Administration today announced important steps to better support consumer access to hearing aids. The agency issued a guidance document explaining that it does not intend to enforce the requirement that individuals 18 and up receive a medical evaluation or sign a waiver prior to purchasing most hearing aids. This guidance is effective immediately. Today, the FDA is also announcing its commitment to consider creating a category of over-the-counter (OTC) hearing aids that could deliver new, innovative and lower-cost products to millions of consumers.






A New Antibody For Treating Acute Lymphocytic Leukemia

A New Antibody For Treating Acute Lymphocytic Leukemia

Of all the drugs being discussed at this year’s meeting of the American Society of Hematology, one caught my attention. The new agent, a monoclonal antibody to CD22 with a toxin attached, is manufactured by Pfizer. It’s called inotuzumab ozogamicin. As that’s a mouthful, some doctors call it Ino.



DC Bead LUMI Radiopaque Drug-Eluting Bead Offers Interventional Radiologists in Canada a Next Generation Treatment Option for Liver Cancer Patients.

New Treatment Option for Liver Cancer Patients

BTG International Canada Inc., a part of global specialist healthcare company BTG (LSE: BTG), has announced the commercial launch of DC Bead LUMI™ in Canada. Launch represents the first market commercialization of DC Bead LUMI™ in the world, with regulatory clearances and launches planned for additional markets worldwide.